Cargando…
Stroke Event Rates and the Optimal Antithrombotic Choice of Patients With Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
The risks of stroke or systemic embolism and major bleeding are considered similar between paroxysmal and sustained atrial fibrillation (AF), and warfarin has demonstrated superior efficacy to aspirin, irrespective of the AF type. However, with the advent of novel oral anticoagulants (NOACs) and ant...
Autores principales: | Chen, Yicong, Zhao, Yuhui, Dang, Ge, Ouyang, Fubing, Chen, Xinran, Zeng, Jinsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291617/ https://www.ncbi.nlm.nih.gov/pubmed/26717376 http://dx.doi.org/10.1097/MD.0000000000002364 |
Ejemplares similares
-
Left atrial deformation and risk of transient ischemic attack and stroke in patients with paroxysmal atrial fibrillation
por: Chen, Jian, et al.
Publicado: (2023) -
Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience
por: Gorczyca, Iwona, et al.
Publicado: (2020) -
Early effects of paroxysmal atrial fibrillation on plasma markers of fibrinolysis
por: Negreva, Mariya, et al.
Publicado: (2016) -
Functional mitral regurgitation: predictor for atrial substrate remodeling and poor ablation outcome in paroxysmal atrial fibrillation
por: Qiao, Yu, et al.
Publicado: (2016) -
Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation: A meta-analysis
por: Qiu, Mei, et al.
Publicado: (2021)